Logo
homeHome
toggle_offCompany ProfilegroupsBoards & Staffsworkspace_premiumMemberships & PartnersschoolAcademy of Journalismperson_addCareerslinkBlog(EN)emailContact Us
list_altOur JournalslightbulbInstruction for AuthorsbookmarkBrieflands PolicieshandshakePublish My Researchplay_circleJournal Management Systemcredit_cardArticle Processing Chargeszoom_inOpen Peer ReviewimagePublishing Services
menu_bookPublish My Book
  1. Brieflands
  2. journals
  3. International Cardiovascular Research Journal
  4. Articles

  5. Lectin-like Oxidized LDL Receptor-1 (LOX-1) Protein Vaccination Reduces Inflammation and Attenuates Atherosclerosis Progression in Atherogenic-Diet Wistar Rats
  6. Scopus by Title (Ref)

International Cardiovascular Research Journal

The Official Annually Journal of Cardiovascular Research Center, Shiraz University of Medical Sciences

homeHome
play_circleCurrent IssuelistAll Issuesplay_circleIn Presscheck_circleAccepted ManuscriptssearchSearch
lightbulbInstructions
errorJournal InformationschoolBoards & CommitteesshareIndexing and Listing Sourcesbar_chartJournal MetricsbalancePublication Ethics and Publication Malpractice Statementassignment_indReviewer and AE Registration FormheadphonesSupportphone_in_talkContact Us
questionAPC
Authors GuideSubmit Manuscript

Scopus by Title (Ref)


1. Immunology of atherosclerosis: problems and prospects of immunotherapy

- Kotlyarov S. , et al.

2. Design and construction of DNA vaccine expressing lectin-like oxidize-LDL receptor-1 (LOX-1) as atherosclerosis vaccine candidate

- Yurina V. , et al.

HomeInstructionsAPC

Articles

  • Current Issue
  • All Issues
  • In Press
  • Accepted Manuscripts
  • Search

About Journal

  • Journal Information
  • Boards & Committees
  • Indexing and Listing Sources
  • Journal Metrics
  • Publication Ethics and Publication Malpractice Statement
  • Reviewer and AE Registration Form
  • Support
  • Contact Us
Support
Submit a Ticket
BrieflandsBrieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.